טוען...
Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab
IMPORTANCE: Understanding adoption of new cancer therapies may help identify opportunities to increase use for high-value indications. OBJECTIVE: To determine whether use of bevacizumab in 2005 to 2006 by oncologists’ peers was associated with greater bevacizumab use among oncologists in 2007 to 201...
שמור ב:
| הוצא לאור ב: | JAMA Netw Open |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Medical Association
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6991243/ https://ncbi.nlm.nih.gov/pubmed/31899533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2019.18586 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|